These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 11846198

  • 1. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y.
    J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
    [Abstract] [Full Text] [Related]

  • 2. Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
    Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y.
    Int J Oral Maxillofac Surg; 1997 Feb; 26(1):51-3. PubMed ID: 9081255
    [Abstract] [Full Text] [Related]

  • 3. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
    Andrade M A, Puga L B, Guerra C C, Molina E J, Capurro C M.
    Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
    [Abstract] [Full Text] [Related]

  • 4. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
    Ruchlemer R, Yinnon AM, Hershko C.
    Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
    Aytaç S, Yildirim I, Ceyhan M, Cetin M, Tuncer M, Kara A, Cengiz AB, Seçmeer G, Yetgin S.
    Turk J Pediatr; 2010 Nov; 52(2):121-5. PubMed ID: 20560245
    [Abstract] [Full Text] [Related]

  • 12. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
    Ben Othman T, Ben Lakhal B, Medini Manai Z, Ladeb S, M'Sadek F, Meddeb B, Ben Abid H, Bel Hadj Ali Z, Hafsia R, Ben Abdeladhim A, Hafsia A.
    Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
    Myoken Y, Sugata T, Myoken Y, Kyo T, Fujihara M, Mikami Y.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
    [Abstract] [Full Text] [Related]

  • 15. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S, Thibbadee C, Santanirand P.
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [Abstract] [Full Text] [Related]

  • 16. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
    Watanabe N, Matsumoto K, Kojima S, Kato K.
    J Pediatr Hematol Oncol; 2011 May; 33(4):270-5. PubMed ID: 21464763
    [Abstract] [Full Text] [Related]

  • 17. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W.
    Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812
    [Abstract] [Full Text] [Related]

  • 18. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.
    Cancer; 2003 Jan 15; 97(2):450-6. PubMed ID: 12518369
    [Abstract] [Full Text] [Related]

  • 19. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
    Oren I, Haddad N, Finkelstein R, Rowe JM.
    Am J Hematol; 2001 Apr 15; 66(4):257-62. PubMed ID: 11279636
    [Abstract] [Full Text] [Related]

  • 20. Intravenous itraconazole for treating invasive pulmonary aspergillosis in neutropenic patients with acute lymphoblastic leukemia.
    Picardi M, Camera A, Luciano L, Ciancia R, Rotoli B.
    Haematologica; 2003 Feb 15; 88(2):ELT01. PubMed ID: 12604432
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.